Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Gestational Diabetes Market Size Shifted, And What Is the Outlook Through 2034?
There has been a robust expansion in the market size of gestational diabetes in the past few years. The market is projected to increase from $8.37 billion in 2024 to reach $9.11 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The growth witnessed in the historic period is credited to factors such as the escalating risk of diabetes, an improvement in the precision of measuring blood glucose levels, a rise in the number of insurance providers, and a surge in the demographic of diabetic patients, underlining the escalating diabetes prevalence.
In the upcoming years, the market size for gestational diabetes is anticipated to experience robust growth. The market is likely to expand to$12.78 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.8%. This escalation during the forecast period can be primarily accredited to factors such as the rising obesity rates, growing adoption of cloud-based project solutions, and an increase in the use of related devices and applications. An unhealthy lifestyle leading to a higher incidence of diabetes, increased awareness about public health, and rising prevalence of diabetes also contribute to this growth. Looking ahead, major trends set to dominate the forecast period include digital apps for diabetes management, closed-loop control systems, technology for diabetes management, enzymatic technology and groundbreaking medical technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp
Which Primay Drivers Are Accelerating Growth in the Gestational Diabetes Market?
The growth of the gestational diabetes market is projected to be driven by the increasing rate of obesity. Individuals who possess a body mass index (BMI) of 30 or higher, therefore having a high amount of body fat that could cause numerous health problems, are considered obese. The rise in obesity is a result of factors like sedentary lifestyles, the intake of high-calorie processed food, genetic factors, along with limited accessibility to healthy food and exercise options. Treatment for gestational diabetes is paramount for obese individuals as their higher tendencies towards insulin resistance and excessive weight gain during pregnancy could potentially cause issues for both the mother and child if not properly addressed. For example, as per the World Health Organization, a Switzerland-based intergovernmental organization, in March 2024, it was indicated that 1 in 8 people worldwide in 2022 were living with obesity. This included a staggering 2.5 billion adults over the age of 18, who were categorized as overweight, among which was a further subset of 890 million individuals dealing with obesity. Among this group, 43% were overweight while 16% were living with obesity. Additionally, 37 million children under 5 years were overweight, with over 390 million children and youngsters between the ages of 5–19 years also overweight, of which 160 million were living with obesity. As such, the continual rise in obesity rates is fueling the growth of the gestational diabetes market.
Which Primary Segments of the Gestational Diabetes Market Are Driving Growth and Industry Transformations?
The gestational diabetesmarket covered in this report is segmented –
1) By Types: Type A1; Type A2; Other Types
2) By Treatment: Monitoring; Drug Treatment; Non-pharmacological treatment
3) By Administration: Oral; Intravenous; Other Administrations
4) By End User: Hospitals; Clinics; Home Care Settings; Diagnostic Centers
Subsegments:
1) By Type A1: Diet-Controlled Gestational Diabetes; Exercise-Controlled Gestational Diabetes
2) By Type A2: Insulin-Controlled Gestational Diabetes; Oral Medication-Controlled Gestational Diabetes
3) By Other Types: Pre-Gestational Diabetes; Gestational Diabetes With Complications
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20818&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Gestational Diabetes Market?# Market?
North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Gestational Diabetes Industry Dynamics?
Leading firms in the gestational diabetes market are honing their focus on creating technologically superior products such as diagnostic kits for gestational diabetes. This focus is geared towards providing speedy, precise, and simple ways for early detection. The diagnostic kit for gestational diabetes serves as a medical instrument that gauges blood glucose levels, subsequently identifying abnormal glucose tolerance in expectant women. This aids in the prompt identification and control of the condition. Take, for example, DirectSens GmbH, a biotech company based in Austria, which in August 2024 unveiled the XpressGT RUO kit. This kit, intended to diagnose conditions such as gestational diabetes, endometriosis, insulin resistance, and liver disease, precisely measures 2-hydroxybutyrate (2-HB) levels. These levels are naturally found in venous blood, the byproduct of normal liver functions. Increased 2-HB levels typically suggest more reductive stress, which is associated with varying endocrine and obesity-related disorders, including insulin resistance. Compatible with any clinical analyzer currently available, the kit offers results in merely 8 minutes, proposing an effective and quick diagnostic alternative.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report
What Parameters Are Used to Define the Gestational Diabetes Market?
Gestational diabetes is a type of diabetes that develops during pregnancy when the body cannot produce enough insulin to regulate blood sugar levels effectively. This condition typically occurs in the second or third trimester and can affect women who have no prior history of diabetes. Gestational diabetes poses risks to both the mother and baby, including high birth weight, preterm birth, and potential development of type 2 diabetes later in life for both. It is often managed through dietary adjustments, exercise, blood sugar monitoring, and sometimes insulin therapy to ensure a healthy pregnancy and delivery.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20818
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model